138220-90-3 Usage
Uses
Used in Pharmaceutical Industry:
(1,3-DIOXO-OCTAHYDRO-ISOINDOL-2-YL)-ACETIC ACID is used as a building block for the synthesis of various drugs and pharmaceuticals. Its versatile reactivity allows for the introduction of different chemical groups, making it a valuable intermediate in the development of new medications.
Used in Agrochemicals Industry:
(1,3-DIOXO-OCTAHYDRO-ISOINDOL-2-YL)-ACETIC ACID has potential applications in the agrochemicals industry, where it can be utilized as a starting material for the synthesis of various agrochemical products.
Used in Materials Science:
(1,3-DIOXO-OCTAHYDRO-ISOINDOL-2-YL)-ACETIC ACID also has potential applications in materials science, where its unique properties and reactivity can be harnessed for the development of new materials with specific characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 138220-90-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,2,2 and 0 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 138220-90:
(8*1)+(7*3)+(6*8)+(5*2)+(4*2)+(3*0)+(2*9)+(1*0)=113
113 % 10 = 3
So 138220-90-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO4/c12-8(13)5-11-9(14)6-3-1-2-4-7(6)10(11)15/h6-7H,1-5H2,(H,12,13)
138220-90-3Relevant articles and documents
Synthesis and anticonvulsant properties of new acetamide derivatives of phthalimide, and its saturated cyclohexane and norbornene analogs
Kamiński, Krzysztof,Obniska, Jolanta,Wiklik, Beata,Atamanyuk, Dmytro
experimental part, p. 4634 - 4641 (2011/11/04)
The synthesis and anticonvulsant properties of new piperazine or morpholine acetamides derived from 2-(1,3-dioxoisoindolin-2-yl)-, 2-(1,3-dioxo-3a,4,5,6,7, 7a-hexahydroisoindol-2-yl-) and (3,5-dioxo-4-azatricyclo[5.2.1.0 2,6]dec-8-en-4-yl)-acetic acid were described. Initial anticonvulsant screening was performed using maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) seizures tests. The neurotoxicity was determined applying the minimal motor impairment rotarod test. The in vivo results revealed that numerous compounds were effective in the MES screen. The most active was 2-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl}isoindoline-1,3-dione (12) that revealed protection in the electrically induced seizures at a dose of 30 mg/kg and 100 mg/kg 0.5 h and 4 h after i.p. administration in mice respectively. This molecule given orally in rats at a dose of 30 mg/kg was more potent than reference anticonvulsant - phenytoin.